- Regulatory information： 加州化妆品安全计划(CSCP)报告成分：报告 - 无论成分在产品中的预期功能如何
- Cleanup Methods： /抗肿瘤药物的预防措施:/ 如果在铺地毯的区域常规制备或管理危险药物，需要特殊设备来清除溢出物。应使用吸收性粉末代替垫子或床单，并按照制造商推荐的时间留在溢出物上。然后应使用专为危险药物清理保留的小型真空装置收集粉末。然后应按照常规程序清洁地毯。应取下并丢弃或清洁真空袋，真空机外部应用洗涤剂清洗并冲洗，然后覆盖存放。受污染的粉末应丢弃到可密封的塑料袋中，与其他受污染的废物材料隔离。或者，使用廉价的...
- Human toxicity extract： 吡拉西坦会分泌到人乳中。
- Medical Surveillance： /抗肿瘤药物的预防措施：/ 目前没有可用于常规监测人员是否接触危险药物的方法。检测致突变物或染色体损伤的测试不具有药物特异性，仅在受控研究中才有价值。尿液化学分析检测危险药物的存在，其灵敏度水平需要能够检测职业暴露，仅限于少数几种药物，尚未商业化。/抗肿瘤药物/
- Non-human toxic extract： J4.157B
- Personal protective equipment (PPE)： /抗肿瘤剂的预防措施：/ 在配制危险药物(如粉碎、溶解和制备软膏)时，工人应穿着低渗透性防护服和双层手套。配制应在防护区域进行，如一次性手套箱。如果必须在开放环境中配制，必须选择远离气流和交通的区域，工人应使用适当的呼吸防护。/抗肿瘤剂/
- Possible routes of human exposure： /抗肿瘤药物的预防措施：/ 医疗人员处理危险药物的危险源于其固有毒性和工作人员在履行职责过程中接触药物的程度。这种接触可能是通过无意中摄入食物上的药物（例如，工作人员的午餐）、吸入药物粉尘或液滴或直接皮肤接触。/抗肿瘤药物/
- Drug Induced Liver Injury： 参考文献：DOI:10.1016/j.drudis.2019.09.022
Warm reminder：
Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.！
Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.
Service Hotline:400-6226-992 ，We will handle it for you as soon as possible, thank you for your support and trust.！
Research chemical 1ml
Research chemical 1ml; supplied for laboratory research, analysis, inspection, and scientific procurement use; specifications: 1ml.
